IART

IART

USD

Integra LifeSciences Holdings Corporation Common Stock

$11.300-0.090 (-0.790%)

Reaalajas hind

Healthcare
Meditsiiniseadmed
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$11.390

Kõrge

$11.600

Madal

$11.220

Maht

0.19M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

880.2M

Tööstusharu

Meditsiiniseadmed

Riik

United States

Kauplemisstatistika

Keskmine maht

1.22M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $11.05Praegune $11.300Kõrge $27.13

Seotud uudised

Analyst Upgrades

Truist Securities Reiterates Hold on Integra Lifesciences, Lowers Price Target to $13

Truist Securities analyst Ravi Misra reiterates Integra Lifesciences with a Hold and lowers the price target from $15 to $13.

Vaata rohkem
Truist Securities Reiterates Hold on Integra Lifesciences, Lowers Price Target to $13
Analyst Upgrades

Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences with a Sell and lowers the price target from $12 to $11.

Vaata rohkem
Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11
Analyst Upgrades

JP Morgan Maintains Underweight on Integra Lifesciences, Raises Price Target to $13

JP Morgan analyst Robbie Marcus maintains Integra Lifesciences with a Underweight and raises the price target from $12 to $13.

Vaata rohkem
JP Morgan Maintains Underweight on Integra Lifesciences, Raises Price Target to $13
GlobeNewswire

Integra LifeSciences Reports Third Quarter 2025 Financial Results

PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today reported financial results for the third quarter ending

Vaata rohkem
Integra LifeSciences Reports Third Quarter 2025 Financial Results